Pediatric Researcher Expresses Frustration With FDA Delay On Ketamine Trial
This article was originally published in The Pink Sheet Daily
Executive Summary
K.J.S. "Sunny" Anand, director of critical care at Le Bonheur Children's Hospital, said he has been waiting two and a half years for the agency to clear an IND for the drug.